BORON GLUCONATE

Possibly Marketed Outside US

First approved in 2009

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C6H11BO8
Molecular Weight	221.958
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC[C@H]1OB(O)O[C@H]1[C@H](O)[C@@H](O)C(O)=O

InChI

InChIKey=KJEUMRLAKARHEP-TXICZTDVSA-N

InChI=1S/C6H11BO8/c8-1-2-5(15-7(13)14-2)3(9)4(10)6(11)12/h2-5,8-10,13H,1H2,(H,11,12)/t2-,3-,4-,5-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C6H11BO8
Molecular Weight	221.958
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	4 / 4
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ams.usda.gov/sites/default/files/media/Calcium%20Borogluconate%20TR.pdf
Curator's Comment: description was created based on several sources, including https://books.google.ru/books?id=Sfmc-fRCj10C&pg=PA58

Boron gluconate is a boron-containing dietary supplement. Calcium salt of boron gluconate is used as a calcium supplement in veterinary to treat hypocalcemia (also called parturient paresis and commonly called milk fever) in cattle, sheep, and goat.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Hypocalcemia 73 Sources: https://www.ams.usda.gov/sites/default/files/media/Calcium%20Borogluconate%20TR.pdf	Curative		Approved 8583	CALJECT Approved Use Calcium salt of boron gluconate is used as a calcium supplement in veterinary to treat hypocalcemia (also called parturient paresis and commonly called milk fever) in cattle, sheep, and goat.

PubMed

Title	Date	PubMed
Cell cycle arrest, extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy.	2013-06	23462526
Effect of boron on osteogenic differentiation of human bone marrow stromal cells.	2011-12	21625915
Analysis of 35 inorganic elements in teeth in relation to caries formation.	2009	19129982

Patents

Sample Use Guides

In Vivo Use Guide

For treatment of hypocalcemia, calcium borogluconate is administered at 1 ml/kg (intravenous, intramuscular, or subcutaneous).

Route of Administration: Other

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:15:40 GMT 2025` Edited by `admin` on `Mon Mar 31 18:15:40 GMT 2025`
Record UNII	X8P2SY4Y7V
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BORICUM GLUCONICUM

Preferred Name

English

BORON GLUCONATE

Common Name

English

Borogluconate [WHO-DD]

Common Name

English

BOROGLUCONATE

Common Name

English

Code System Code Type Description

RXCUI

1370421